Functional Model of Metabolite Gating by Human Voltage-Dependent Anion Channel 2 by Bauer, Andras J. et al.
Published: March 22, 2011
r2011 American Chemical Society 3408 dx.doi.org/10.1021/bi2003247|Biochemistry 2011, 50, 3408–3410
RAPID REPORT
pubs.acs.org/biochemistry
FunctionalModelofMetaboliteGatingbyHumanVoltage-Dependent
Anion Channel 2
AndrasJ.Bauer,
†SimoneGieschler,
‡KathrynM.Lemberg,
†AnnE.McDermott,*
,‡andBrentR.Stockwell*
,†,‡
†Howard Hughes Medical Institute, Department of Biological Sciences, Northwest Corner Building, 12th ﬂoor, 550 West 120th Street
MC 4846, New York, New York 10027, United States
‡Department of Chemistry, Columbia University, 3000 Broadway, New York, New York 10027, United States
b S Supporting Information
ABSTRACT: Voltage-dependent anion channels (VDACs)
are critical regulators of outer mitochondrial membrane
permeability in eukaryotic cells. VDACs have also been
postulated to regulate cell death mechanisms. Erastin, a
small molecule quinazolinone that is selectively lethal to
tumor cells expressing mutant RAS, has previously been
reported as a ligand for hVDAC2. While signiﬁcant eﬀorts
have been made to elucidate the structure and function of
hVDAC1, structural and functional characterization of
hVDAC2 remains lacking. Here, we present an in vitro
system that provides a platform for both functional and
structural investigation of hVDAC2 and its small molecule
modulator, erastin. Using this system, we found that erastin
increases permeability of VDAC2 liposomes to NADH in a
manner thatrequires the amino-terminal region of VDAC2.
Furthermore, we conﬁrmed that this VDAC2-lipsome sam-
ple is folded using solid-state NMR.
V
oltage-dependent anion channel (VDAC) proteins are eu-
karyotic porins that provide the major route for metabolite
traﬃcking across the mitochondrial outer membrane. VDACs
are also involved in cell death and are therefore of great interest
for their role in health and disease.
1 Humans possess three
isoforms ofVDAC channels;todateVDAC1,themajorisoform,
is the best characterized. Recently, the high-resolution structure
of VDAC1 has been elucidated by both solution-state and solid-
state NMR as well as X-ray crystallography,
2,3 revealing a
19-stranded β-barrel fold with an N-terminal helical segment.
In contrast, biophysical and structural characterization of VDAC
isoforms 2 and 3 islacking. VDAC2 and 3 havedistinct functions in
cell death and serve as targets of the small molecule erastin, which
triggers a previously unobserved form of tumor cell death
4
(Figure 1a and Figures S1 and S2 of the Supporting Information).
Although VDAC2 is known to interact with and inhibit the pro-
apoptotic protein Bak,
5 cell death mediated by erastin occurs by a
nonapoptotic mechanism involving VDAC2 and VDAC3. A hall-
mark of erastin-induced cell death is the formation of reactive
oxygen species, raising the possibility that erastin acts by aﬀecting
metabolite gating. Modulation of VDAC2 or VDAC3 metabolite
gating activity may be a new approach to target disease, and
knowledge of the erastinVDAC2 interaction should improve
our understanding of VDAC2 structurefunction relationship.
To gain insight into the eﬀects of erastin on hVDAC2, we
developed an in vitro model of hVDAC2 that permits interrogation
of structural and functional properties of puriﬁed hVDAC2. We
puriﬁed recombinant His6-tagged hVDAC2 protein from inclusion
bodies, followed by on-column refolding in the presence of
detergents(see Supporting Information).
4Similarto whathasbeen
reported for native VDAC,
6 this hVDAC2 protein reconstituted
intotheplanarlipidmembraneformsatypicalVDACsinglechannel
with characteristic gating behavior at high potentials (see Figure S3
of the Supporting Information).
Full-length hVDAC2 was incorporated into liposomes with near
100% eﬃciency (see Figure S4 of the Supporting Information) by
mixing the protein with a lipid mixture of phosphatidylcholine and
phosphatidylserineina4:1massratio.Becausepreviousstudieshave
indicatedtheimportanceofcholesterol
7inreconstitutingVDACsin
afunctionalconformation,weincluded0.1mg/mLcholesterol(see
Supporting Information on exact precipitation procedure). The
creation of liposomes was veriﬁed by CryoEM (Figure 1b and
Figure S5 of the Supporting Information).
We sought to evaluate the structural integrity of precipitated
hVDAC2 liposomes using solid-state NMR. In the past few years,
this technique has emerged as a capable method for the investigation
of integral membrane proteins
810 and has recently been applied to
structure determination of the N-terminal helix of VDAC1.
11 We
prepareduniformly
13C-labeledhVDAC2andfoundthathVDAC2is
foldedundertheconditionsusedforfunctionalassays(seebelowand
Supporting Information for sample preparation and additional
spectra). A two-dimensional
13C
13C dipolar-assisted rotational
resonance (DARR
10) spectrum, which can be considered the
“ﬁngerprint”of the protein, diﬀerentiates between peaks arising from
R-helicalresiduesandthosefromtheβ-barrel,basedon
13Cchemical
shift of the backbone and side-chain carbon atoms (Figure 2a).
ResonancesofAla(Figure2b),ThrandSer(Figure2c),withastrong
structural chemical shift dependence of backbone resonances are
highlighted; they all lie within expected chemical shift ranges for
β-strands, in good correspondence with published structures of
mVDAC1. The alanine resonances also indicate the presence of a
helical environment. The strong resonances observed for aromatic
residuesalsoindicatethepresenceofafoldedprotein(seeSupporting
Information). On the basis of a comparison of the observed shift
regions and structure-based statistics,
12 we conclude that hVDAC2 is
in a β-barrel-like conformation, as expected from structural studies of
Received: March 3, 2011
Revised: March 22, 20113409 dx.doi.org/10.1021/bi2003247 |Biochemistry 2011, 50, 3408–3410
Biochemistry RAPID REPORT
VDAC1. An overlay of the erastin-treated and untreated samples
revealschemicalshiftchanges,mostnotablyintheβ-strandthreonine
region, indicating that erastin may aﬀect these residues by binding on
the inside of the pore (see Figure S6 of the Supporting Information).
PoresizeisakeyindicatorofcorrectfoldinginVDACproteins.As
an assessment of pore size for the liposome-incorporated hVDAC2,
we monitored shrinkage and swelling of liposomes induced by
osmolytes of varying sizes by light scattering.
13 In agreement with
previous observations in liposomes containing mitochondrially iso-
latedVDAC2,theseexperimentsrevealedthatosmolytessmallerthan
4 kDa can pass through the VDAC2 pore, while larger osmolytes do
not inducereswelling (seeFigureS8 of the Supporting Information).
SmallmoleculemodulatorsofVDACs,suchaserastin,mayactby
perturbing VDAC metabolite gating. To test this hypothesis, we
developed an assay to monitor the passage of NADH through the
VDAC2pore.Incells,NADHservesasakeysubstrateandregulator
of hVDAC2.
14,15 To monitor NADH transport through the
hVDAC2 pore, we introduced bovine lactate dehydrogenase
(LDH)intoliposomesbysonication(seeSupportingInformation).
LDHservestooxidizeNADHenteringtheliposome,aprocessthat
is limited by VDAC2 permeability and which can be easily
monitored by observing the decrease in absorption of NADH at
340 nm (see Figure S8 of the Supporting Information).
Liposomes containing hVDAC2 were subjected to the LDH-
coupled gating assays and were found to have slower rates of NADH
oxidation than samples containing LDH alone, while empty lipo-
somesandliposomescontainingLDH,butnoVDAC2,showedlittle-
to-no NADH oxidation (see Supporting Information). These data
indicate that NADH enters the liposomes almost exclusively through
the hVDAC2 pore.
ErastinwaspreviouslyshowntobindhVDAC2withaKdvalue
of 112 nM.
4 We evaluated the eﬀect of erastin on NADH
traﬃcking through hVDAC2. hVDAC2-liposome samples were
incubated with varying concentrations of erastin or an inactive
analogue, erastin A8, prior to NADH oxidation assays. By
comparing the rates of NADH oxidation in DMSO-treated
liposomes and compound-treated liposomes, we determined
that erastin treatment increases VDAC2 permeability to NADH
by50.1(5.1% withameanEC50=52.6(28.2nM(Figure1c).
Incontrast,erastin A8(Figure 1a)failedtotriggerasimilareﬀect
at any concentration tested.
WetheninvestigatedthepossibleinvolvementoftheN-terminal
loop in VDAC2 gating and erastin binding by expressing a
truncated version of hVDAC2 lacking the ﬁrst 20 amino acids
(ΔhVDAC2).N-terminaltruncationsofVDACshavepreviously
been described to be functional in lipid-bilayer gating experi-
ments but show altered voltage-dependence and decreased
initiation of cell death.
16 LDH-coupled gating assays with
ΔhVDAC2 liposomes exhibited 30.6 ( 1.6% lower permeation
rates than observed for the wild-type hVDAC2 (see Figure S9 of
the Supporting Information). Erastin had no eﬀect on NADH
permeability in ΔhVDAC2 liposomes at sub-micromolar con-
centrations, suggesting involvement of the N-terminal region in
mediating erastin’se ﬀect on metabolite gating. At the highest
concentration tested, 10 μM, a strong positive eﬀect was
observed on NADH permeability (Figure 1d). Consistent with
these data is the observation that N-terminal mutants of Neuro-
spora crassa VDAC have an increased preference for the cation
selective“closed”state.
17TheN-terminaldeletionofΔhVDAC2
may similarly shift the channel into the closed state and cause a
decreased basal rate of NADH permeation through the channel,
thus amplifying an eﬀect of high concentrations of erastin in our
Figure 1. Eﬀect of erastin and erastin A8 on NADH transport through
hVDAC2. (a) Structure of erastin and its inactive analogue, erastin A8. (b)
hVDAC2-containingliposomesvisualizedbyCryoEM.(c)RelativeNADH
oxidation rates in wild-type VDAC2-containing liposomes, normalized to
oxidation rates observed with DMSO treatment. (d) Relative NADH
oxidation rates in N-terminal-truncated VDAC2-containing liposomes,
normalized to oxidation rates observed with DMSO treatment.
Figure2. TheCRCβandCOregionofthe
13C
13CDARR
11spectrafor
au n i f o r m l y
15N
13C-labeled sample of hVDAC2 shown in red contours,
and in the presence of erastin in blue contours (hVDAC2e; 750 MHz
AVANCE spectrometer with sample spinning at 14 kHz). Dashed lines
representspectralconnectivitiesof
13CR
13Cβand
13CObackbonenuclei
of residues with strong dependence on secondary structure, alanine
(CRstrand 50.86 ( 1.28 ppm, CRhelix 54.86 ( 0.94 ppm, CRcoil 52.67 (
1.76ppmand Cβstrand21.72 (1.77ppm, Cβhelix18.27(1.08 ppm,Cβcoil
19.03 ( 1.77 ppm), serine (CRstrand 57.14 ( 1.11 ppm, Cβstrand 65.39 (
1.48 ppm), and threonine (CRstrand 56.28 ( 1.52 ppm, Cβstrand 70.82 (
2.11 ppm). Common chemical shifts for backbone carbons for these
residues based on the structural environment are given in parentheses.
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analysis.Whateverthemechanism,thehighconcentrationmakes
it less relevant to erastin’s activity in cells.
Inconclusion,wehavecreatedaninvitrofunctionalsystemfor
monitoring metabolite gating of hVDAC proteins, a system that
enables side-by-side structural and functional study of these
proteins. Using this system, we determined that erastin aﬀects
metabolite gating of hVDAC2, leading to a better understanding
of erastin’s mechanism of action. These studies should aid in
understanding VDAC2 gating mechanisms and in developing
novel antitumor agents.
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